RYZUMVI

Drug Oyster Point Pharma, Inc.
Total Payments
$44,936
Transactions
479
Doctors
353
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $44,936 479 353

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $30,992 13 69.0%
Food and Beverage $13,945 466 31.0%

Top Doctors Receiving Payments for RYZUMVI — Page 15

Doctor Specialty Location Total Records
, MD Ophthalmology Great Neck, NY $10.25 1
, MD Ophthalmology New York, NY $7.36 1
, OD Optometrist Syracuse, NY $3.72 1
«1…131415

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $44,936
  • Total Doctors 353
  • Transactions 479

About RYZUMVI

RYZUMVI is a drug associated with $44,936 in payments to 353 healthcare providers, recorded across 479 transactions in the CMS Open Payments database. The primary manufacturer is Oyster Point Pharma, Inc..

Payment data is available from 2024 to 2024. In 2024, $44,936 was paid across 479 transactions to 353 doctors.

The most common payment nature for RYZUMVI is "Consulting Fee" ($30,992, 69.0% of total).